Fiduciary Alliance’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Buy |
4,360
+323
| +8% | +$26.8K | 0.03% | 360 |
|
|
2025
Q1 | $327K | Sell |
4,037
-483
| -11% | -$39.2K | 0.03% | 302 |
|
|
2024
Q4 | $407K | Sell |
4,520
-19,446
| -81% | -$1.75M | 0.04% | 257 |
|
|
2024
Q3 | $2.37M | Buy |
23,966
+648
| +3% | +$64K | 0.31% | 79 |
|
|
2024
Q2 | $2.13M | Buy |
23,318
+285
| +1% | +$26K | 0.35% | 69 |
|
|
2024
Q1 | $2.16M | Buy |
23,033
+1,789
| +8% | +$168K | 0.38% | 64 |
|
|
2023
Q4 | $1.9M | Sell |
21,244
-237
| -1% | -$21.2K | 0.37% | 58 |
|
|
2023
Q3 | $1.57M | Buy |
21,481
+593
| +3% | +$43.3K | 0.36% | 56 |
|
|
2023
Q2 | $1.74M | Buy |
20,888
+1,768
| +9% | +$147K | 0.37% | 59 |
|
|
2023
Q1 | $1.46M | Sell |
19,120
-348
| -2% | -$26.5K | 0.37% | 63 |
|
|
2022
Q4 | $1.62M | Buy |
+19,468
| New | +$1.62M | 0.42% | 58 |
|